Oral Clinical Nutrition Market Size, Share & Trends Analysis Report By Stage (Adults, Pediatrics), By Indication (Dysphagia, Alzheimer’s), By Sales Channel, By Region, And Segment Forecasts, 2023 - 2030

Report Overview

The global oral clinical nutrition market size was valued at USD 15.6 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 5.0% from 2023 to 2030. The rising prevalence of malnutrition among the adult population and the increase in the instances of obesity, rising chronic diseases such as cancer, diabetes are the major factors boosting the market growth. Oral clinical nutrition includes vitamins, proteins, and carbohydrates in powder, liquid, and semi-solid forms for oral consumption. The key market players manufacturing oral clinical nutrition products are advancing them with new flavors to enhance the taste and thereby, capture a larger customer base. This enhances the sale of oral nutritional products, which spurs the market demand.

The rising prevalence of cancer cases has led to increasing demand for nutritious food. This is due to the side effects of cancer treatment that lead to the loss of appetite, and malnutrition issues among the adult population such as loss of essential body nutrition proteins and vitamins. For instance, in an article published by the National Cancer Institute, Columbia, 2018, cancer cases will increase and reach 23.6 million by 2030. This will drive the global oral clinical nutrition market. Researchers and scientists are developing approaches to formulate nutritional products to improve nutrition deficiency and quality of life for cancer patients.

An unhealthy lifestyle leads to an increasing burden of health issues such as lack of nutrition, obesity, poor immunity leading to the rise of chronic, neurological and autoimmune diseases. In the market, key players have involved themselves in strategic initiatives involving collaboration, mergers, agreements, and acquisitions to expand the nutrition portfolio. This will propel the global market. For instance, in May 2022, Nestle Health Science agreed to acquire Puravida to expand the NHSc portfolio of nutrition segment in Brazil. The nutrition portfolio will include minerals, herbals, and vitamins supplements, nutritional beverages using plant-based foods. Eventually, this is likely to enhance the nutritional content and quality of the supplements.

Moreover, the market leaders and innovators are involved in novel product launch to enhance productivity, durability, quality, and improve the nutritional value of the food products. Along with the nutritional value, the manufacturers of clinical nutrition products are working to enhance and improve the taste of the products by incorporating different flavors. Due to this, there is more demand for oral clinical nutrition products which drives the global market. For instance, in March 2021, Kate Farms launched two products covering Medi-Cal insurance for children and adults. The products, Kate Farms Standard 1.4 Vanilla and Plain, and Kate Farms Pediatric Peptide Vanilla Flavor 1.0 are indicated to treat nutrient deficiency in patient with chronic diseases such as allergies, malnutrition in adults, cancer, and gastrointestinal disorders. Such novel product inventions are expected to drive industry growth.

The outbreak of COVID-19 had a significant impact on the oral clinical nutrition market. The viral infection led to a decrease in the immunity in the patient. Moreover, the conditions such as hypertension, obesity and diabetes were also some of the major risk factors resulting in poor clinical outcomes for hospitalized patients due to SARS-CoV-2 infection. As per the clinical studies, the population over 50-65 age was more prone to lower immunity, poor nutrition and condition such as sarcopenia. There is a rise in demand for oral clinical nutrition supplements to enhance the body immunity driving the overall market. Various public and private entities involved in R&D and research have started developing oral clinical nutrition solutions for COVID-19-infected patients to cater to the issues of nutritional deficiency. Moreover, there is a rise in the number of clinical studies to understand the potential benefits and effects of Vitamin D, and Vitamin C nutritional supplements for the treatment of patients with COVID-19 infection, which is further expected to drive the global market.

Stage Insights

By stage, the adult segment held the largest share of 87.8% in 2022. This is attributed to the increasing prevalence of nutritional deficiency and malnutrition among the adult population. The adult age group is more prone to reduced muscle strength, vitamins, apathy, lower immunity, hypertension, and fatigue, and calcium deficiency among the women population of the age group above 30 years. This results in nutritional deficiency among the adult population. The rise in awareness among people and healthcare professionals to treat such deficiencies has resulted in an increased demand for oral clinical nutrition products. For instance, as per the NIH report of 2019, the sale of multivitamins and mineral supplements increased to 38% for adults in the U.S., which generated a revenue of $55.7 billion in 2020.

Furthermore, the segment is also anticipated to grow at the fastest rate in the forecast period owing to the rising consumption of alcohol, smoking leading to chronic diseases such as cancer. An unhealthy lifestyle and subsequent rise in the prevalence of chronic diseases have also led to an increase in hospital admissions among the adult population. Moreover, the researchers and healthcare workers are engaged in finding effective treatments.

Indication Insights

By Indication, the cancer care segment held the largest share of 15.32% in 2022. This is due to the fact that unhealthy lifestyle, environment, eating habits, inherited traits, and poor immunity has increased the occurrence of genetic disorders. The prevalence of cancer is increasing globally. In the surge for early diagnosis and treatment of cancer symptoms, advanced treatments such as chemotherapy and radiation therapy are implemented. The side effects of these treatments result in poor food intake, a decrease in body nutrition, and malnutrition among the patients. For instance, in April 2020, Esperer Onco Nutrition launched oral clinical nutrition supplements Es-Fortitude and Es-Invigour which can be consumed orally by patients who suffered weight loss due to chemotherapy and other cancer treatments.

The Malabsorption/GI Disorder/Diarrhea segment is anticipated to witness the fastest growth in the forecast period. This is attributed to the rising prevalence of these diseases among infants and children. Malabsorption and GI disorders are most commonly seen among infants. Thus, there are oral nutrition products available in the market to treat these indications. The industry players are engaged in increasing their production to cater to the growing market demand. For instance, Neocate nutrition supplements developed by Nutricia such as Neocate- Syneo Infant, Infant DHA/ARA, Nutra, Junior, Splash are some of the oral nutrition products used to treat malabsorption, GI disorders FPIES, eosinophilic esophagitis. In June 2022,  Nutricia has started increasing the production and manufacturing of Neocate products to meet their rising demand. Thus, the increasing demand for oral clinical nutrition products to combat nutrient deficiency and boost the immune response among patients is expected to drive market growth.

Sales Channel Insights

By Sales channel, the institutional sales segment held the largest share of 42.5% in 2022. The sales channel includes commercial sales to government organizations, hospitals, and research institutes. The rising prevalence of diseases and advancements in hospital care leads to a rise in patient visits to hospitals which drives the segment. Oral supplements prescribed by doctors are the first line of treating chronic diseases to improve nutrient deficiency.

The online sales segment is anticipated to witness the fastest growth over the forecast period. Online shopping has become convenient and easy as it saves time and travel burdens. Hence, there is an increase in online sales due to the rising customer demand for oral clinical nutrition supplements via online platforms and stores. This drives the segment to grow at a lucrative pace in the forecast period.

Regional Insights

In 2022, North America dominated the oral clinical nutrition market with a share of 30.1%. The increasing number of patients with non-communicable diseases, such as diabetes and hypertension, cancer and CKDs, is expected to promote the demand for oral clinical nutritional products in this region. Moreover, rising initiatives amongst the pharmaceutical companies and food & nutrition companies to expand their portfolio is driving the segment growth. For instance, in April 2019, Nutrasource entered into a strategic partnership with Greene Concepts, Inc., a leader in the formulated beverages industry. This partnership enabled the expansion of its Ready-To-Drink (RTD) beverage products as well as dietary supplements in North America.

Asia Pacific is anticipated to witness the fastest growth in the forecast period. This is due to the developing healthcare facilities, better healthcare reimbursement policies, government initiatives in the healthcare sectors and better economic growth which positively boosts the market growth. In addition, the presence of key players in this region is also one of the key factors driving regional growth.

Key Companies & Market Share Insights

Various strategies such as product development, partnerships, funding, investments, etc. adopted by key players are driving the market. For instance, in September 2021, Abbott relaunched PediaSure Harvest and Ensure Harvest products with plant-based protein and organic food ingredients. It can be used as a sole source of nutrition or as a supplement for individuals to meet daily nutrition requirements. In August 2019, Nestlé Health Science acquired Persona, a personalized vitamin business company. Through this acquisition, the company would expand its business in the personalized nutrition segment. Some prominent players in the global oral clinical nutrition market

• Abbott Laboratories

• Pfizer Inc.

• Bayer AG

• Nestle S.A.

• GlaxoSmithKline plc

• Baxter International Inc.

• Otsuka Holdings Co., Ltd.

• Mead Johnson & Company, LLC

• Danone Nutricia, Victus, Inc.

Oral Clinical Nutrition Market Report Scope

Global Oral Clinical Nutrition Market Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global oral clinical nutrition market report based on stage, indication, sales channel, and region:

• Stage Outlook (Revenue, USD Million, 2018 - 2030)

  • Adults

  • Pediatrics

• Indication Outlook (Revenue, USD Million, 2018 - 2030)

  • Alzheimer’s

  • Nutrition Deficiency

  • Cancer Care

  • Diabetes

  • Chronic Kidney Diseases

  • Orphan Diseases

  • Dysphagia

  • Pain Management

  • Malabsorption/GI Disorder/Diarrhea

  • Others

• Sales Channel Outlook (Revenue, USD Million, 2018 - 2030)

  • Online Sales

  • Retail Sales

  • Institutional Sales

• Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America

    • U.S.

    • Canada

  • Europe

    • U.K.

    • Germany

    • France

    • Italy

    • Spain

    • Sweden

    • Norway

    • Denmark

  • Asia Pacific

    • Japan

    • China

    • India

    • South Korea

    • Australia

    • Thailand

  • Latin America

    • Brazil

    • Mexico

    • Argentina

  • MEA

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait